M3 Wake Research

M3 Wake Research is a leading clinical trial network established in 1984, with a primary focus on connecting patients to Phase I-IV trials while enhancing health outcomes and quality of life. The network boasts over 30 years of experience in conducting a diverse range of studies. It has built a robust subject database, offering substantial potential for clinical trial participants, with an expanding network extending across the country. The network comprises premier investigational sites that are fully integrated, aiming to deliver exceptional clinical trial experiences for patients, sponsors, and CROs. M3 Wake Research provides a comprehensive suite of clinical trial services, from study design to completion, catering to the requirements of global biopharmaceutical, biotechnology, medical device, and pharmaceutical industry leaders. The board-certified physicians at M3 Wake Research have successfully completed over 7,000 clinical trials with a strong focus on integrity, human protection, and the prompt and accurate delivery of evaluable data. The network's unwavering commitment to superior quality in planning and executing each study in compliance with regulations sets them apart. M3 Wake Research consistently surpasses sponsor expectations in terms of integrity, subject enrollment, human protection, and the timely delivery of accurate evaluable data. For clinical trials that not only meet but exceed expectations, M3 Wake Research is the go-to choice.